Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine
about
Synthesis and immunological effects of heroin vaccinesCharacterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines.Adjuvants for vaccines to drugs of abuse and addiction.Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriersSynthesis of Hapten-Protein Conjugate Vaccines with Reproducible Hapten Densities.A simple nonradioactive method for the determination of the binding affinities of antibodies induced by hapten bioconjugates for drugs of abuseConjugate Vaccine Immunotherapy for Substance Use Disorder.Current status and future prospects for the development of substance abuse vaccines.Development of a Clinically Viable Heroin Vaccine.Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant.A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse.A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids.
P2860
Q34098122-13B4EE6B-BAF1-4D45-8FAE-C1AD362F473EQ34144813-5490D2BA-2E49-48D1-AA81-2C7F4A50723BQ35493923-32F1BF7A-10B8-4B82-875D-C32658A77387Q35756201-42D4B3A9-18F6-4EA3-8F66-684862DB4140Q35989208-6ECA4D5B-91DF-48CD-BD4D-D1CE0278B746Q36480112-CCCD6C35-80E4-4DE2-858D-807BC88FA447Q39387013-144DE5C4-6080-4F14-991D-1204326374D1Q43076031-CCEEEEB4-E116-4522-8761-BE9277F0CEF3Q45060547-9E187852-E602-4A81-B2BA-3D20C55D3701Q47105347-CBC0D3FB-1B31-40C5-B17F-B05A6A670C67Q47253367-F55A4454-C6D7-4EB4-8700-484A52C59443Q52575567-9F03C7C6-FAB3-4E5F-AFAF-1C6748ED8F7F
P2860
Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Facial recognition of heroin v ...... 6-acetylmorphine, and morphine
@ast
Facial recognition of heroin v ...... 6-acetylmorphine, and morphine
@en
type
label
Facial recognition of heroin v ...... 6-acetylmorphine, and morphine
@ast
Facial recognition of heroin v ...... 6-acetylmorphine, and morphine
@en
prefLabel
Facial recognition of heroin v ...... 6-acetylmorphine, and morphine
@ast
Facial recognition of heroin v ...... 6-acetylmorphine, and morphine
@en
P2093
P2860
P1433
P1476
Facial recognition of heroin v ...... 6-acetylmorphine, and morphine
@en
P2093
Alexander V Mayorov
Arthur E Jacobson
Carl R Alving
Joshua F G Antoline
Kejun Cheng
Kenner C Rice
Malliga R Iyer
Oscar B Torres
Zoltan Beck
P2860
P304
P356
10.1016/J.VACCINE.2014.01.028
P407
P577
2014-01-28T00:00:00Z